These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model. Bloomer WD; Adelstein SJ Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561 [TBL] [Abstract][Full Text] [Related]
6. Bystander effect produced by radiolabeled tumor cells in vivo. Xue LY; Butler NJ; Makrigiorgos GM; Adelstein SJ; Kassis AI Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13765-70. PubMed ID: 12368480 [TBL] [Abstract][Full Text] [Related]
7. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy. Bloomer WD; Adelstein SJ Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377 [TBL] [Abstract][Full Text] [Related]
8. Measurement of the intensity ratio of Auger and conversion electrons for the electron capture decay of Alotiby M; Greguric I; Kibédi T; Lee BQ; Roberts M; Stuchbery AE; Tee P; Tornyi T; Vos M Phys Med Biol; 2018 Mar; 63(6):06NT04. PubMed ID: 29480815 [TBL] [Abstract][Full Text] [Related]
9. Microdosimetric basis of individualized cancer radiotherapy by radionuclides including Auger effect and the photon activation approach. Booz J Strahlentherapie; 1984 Dec; 160(12):745-54. PubMed ID: 6393457 [No Abstract] [Full Text] [Related]
10. On the equivalent dose for Auger electron emitters. Howell RW; Narra VR; Sastry KS; Rao DV Radiat Res; 1993 Apr; 134(1):71-8. PubMed ID: 8475256 [TBL] [Abstract][Full Text] [Related]
12. [Experimental radiotherapy, a research plan from radiobiology]. Hagen U Strahlenschutz Forsch Prax; 1985; 26():28-30. PubMed ID: 4089905 [No Abstract] [Full Text] [Related]
13. Strategies for selective targeting of Auger electron emitters to tumor cells. O'Donoghue JA J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202 [TBL] [Abstract][Full Text] [Related]
14. 125I interstitial implants in the RIF-1 murine flank tumor: an animal model for brachytherapy. Bernstein M; Gutin PH; Weaver KA; Deen DF; Barcellos MH Radiat Res; 1982 Sep; 91(3):624-37. PubMed ID: 6750681 [No Abstract] [Full Text] [Related]
15. Molecular consequences of the Auger effect: the fate of iododeoxyuridine following iodine-125 decay. Keough G; Hofer KG Radiat Res; 1976 Aug; 67(2):224-34. PubMed ID: 948550 [No Abstract] [Full Text] [Related]
17. Photon activation of iododeoxyuridine: biological efficacy of Auger electrons. Laster BH; Thomlinson WC; Fairchild RG Radiat Res; 1993 Feb; 133(2):219-24. PubMed ID: 8438063 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. DeSombre ER; Shafii B; Hanson RN; Kuivanen PC; Hughes A Cancer Res; 1992 Oct; 52(20):5752-8. PubMed ID: 1394199 [TBL] [Abstract][Full Text] [Related]
19. The Auger cascade and therapeutic applications of 125I. Feige Y Curr Top Radiat Res Q; 1978 Jan; 12(1-4):3-11. PubMed ID: 639553 [TBL] [Abstract][Full Text] [Related]
20. Potential for tumor therapy with iodine-125 labeled immunoglobulins. Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]